Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years

L. Morgante, G. Basile, A. Epifanio, E. Spina, A. Antonini, F. Stocchi, E. Di Rosa, G. Martino, R. Marconi, P. La Spina, V. Nicita-Mauro, A. E. Di Rosa

Research output: Contribution to journalArticle

Abstract

This study was performed to assess whether patients with Parkinson's disease (PD) develop cognitive and psychiatric impairments more frequently during therapy with continuous subcutaneous apomorphine infusion (CAI) compared to the standard oral treatment. Thirty consecutive PD patients with severe motor fluctuations were included. Of them, 12 patients received the CAI treatment, while the remaining 18 continued the treatment with oral dopaminergic drugs. The two groups were evaluated with neuropsychological, psychiatric and motor tests at baseline and after two years. The off-awake daily duration and the levodopa dosage were significantly reduced in the patients infused with apomorphine. In comparison with the baseline evaluation, the neuropsychiatric assessment did not change in either of groups at the follow-up, except for a significant improvement of mood in the CAI treated group.

Original languageEnglish
Pages (from-to)291-296
Number of pages6
JournalArchives of Gerontology and Geriatrics
Volume38
Issue numberSUPPL.
DOIs
Publication statusPublished - 2004

Keywords

  • Continuous apomorphine infusion
  • Neuropsychiatric impairments
  • Parkinson's disease

ASJC Scopus subject areas

  • Ageing
  • Medicine(all)

Fingerprint Dive into the research topics of 'Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years'. Together they form a unique fingerprint.

  • Cite this

    Morgante, L., Basile, G., Epifanio, A., Spina, E., Antonini, A., Stocchi, F., Di Rosa, E., Martino, G., Marconi, R., La Spina, P., Nicita-Mauro, V., & Di Rosa, A. E. (2004). Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years. Archives of Gerontology and Geriatrics, 38(SUPPL.), 291-296. https://doi.org/10.1016/j.archger.2004.04.039